SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000893220-07-002581
Filing Date
2007-07-30
Accepted
2007-07-30 17:03:47
Documents
5
Period of Report
2006-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A w37423e10vqza.htm 10-Q/A 738631
2 CERTIFICATION OF PRESIDENT AND CHIEF EXECUTIVE OFFICER w37423exv31w1.htm EX-31.1 8076
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER w37423exv31w2.htm EX-31.2 8049
4 CERTIFICATION OF CEO PURSUANT TO 18 U.S.C. SECTION 1350 w37423exv32w1.htm EX-32.1 3958
5 CERTIFICATION OF CFO PURSUANT TO 18 U.S.C. SECTION 1350 w37423exv32w2.htm EX-32.2 4016
  Complete submission text file 0000893220-07-002581.txt   764245
Mailing Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677
Business Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 845-425-7100
PAR PHARMACEUTICAL COMPANIES, INC. (Filer) CIK: 0000878088 (see all company filings)

IRS No.: 223122182 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q/A | Act: 34 | File No.: 001-10827 | Film No.: 071010175
SIC: 2834 Pharmaceutical Preparations